Get introduced to the
most exciting companies in
our portfolio.

BiomX discovers and develops innovative microbiome therapeutics. The company's mission is to develop novel therapeutics for preventing and treating diseases in which microbiome imbalances have been implicated. BiomX's microbiome modulation technologies are based on the cutting-edge innovative research of its scientific collaborators: Professor Rotem Sorek, PhD, and Dr. Eran Elinav, MD, PhD, both of the Weizmann Institute of Science, and Professor Timothy K. Lu, MD, PhD, of the Massachusetts Institute of Technology.